The FDA has approved Glenmark's generics DermOtic Oil and Westcort ointment, which had a market value of about $18.1 million, and $11.1 million respectively.
Novadoz has received FDA clearance for generic Rapaflo, which is indicated for the symptomatic relief in men experiencing the condition benign prostatic hyperplasia.
Lupin has received the Food and Drug Administration's OK for generic Onfi, and tentative nod for generic Adcirca, with a value of $601.2 million and $503.8 million, respectively.